Global Parkinson’s Disease Treatment Market Size, Status and Forecast 2019-2025

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered: Ranking by Parkinson’s Disease Treatment Revenue
• 1.4 Market Analysis by Type
  • 1.4.1 Global Parkinson’s Disease Treatment Market Size Growth Rate by Type: 2020 VS 2026
  • 1.4.2 Oral
  • 1.4.3 Transdermal
  • 1.4.4 Subcutaneous
  • 1.4.5 Intestinal Infusion
• 1.5 Market by Application
  • 1.5.1 Global Parkinson’s Disease Treatment Market Share by Application: 2020 VS 2026
  • 1.5.2 Hospital Pharmacy
  • 1.5.3 Retail Pharmacy
  • 1.5.4 Online Pharmacy
• 1.6 Coronavirus Disease 2019 (Covid-19): Parkinson’s Disease Treatment Industry Impact
  • 1.6.1 How the Covid-19 is Affecting the Parkinson’s Disease Treatment Industry
    • 1.6.1.1 Parkinson’s Disease Treatment Business Impact Assessment - Covid-19
    • 1.6.1.2 Supply Chain Challenges
    • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  • 1.6.2 Market Trends and Parkinson’s Disease Treatment Potential Opportunities in the COVID-19 Landscape
  • 1.6.3 Measures / Proposal against Covid-19
    • 1.6.3.1 Government Measures to Combat Covid-19 Impact
    • 1.6.3.2 Proposal for Parkinson’s Disease Treatment Players to Combat Covid-19 Impact
• 1.7 Study Objectives
• 1.8 Years Considered

2 Global Growth Trends by Regions

• 2.1 Parkinson’s Disease Treatment Market Perspective (2015-2026)
• 2.2 Parkinson’s Disease Treatment Growth Trends by Regions
  • 2.2.1 Parkinson’s Disease Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Parkinson’s Disease Treatment Historic Market Share by Regions (2015-2020)
  • 2.2.3 Parkinson’s Disease Treatment Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis
  • 2.3.5 Parkinson’s Disease Treatment Market Growth Strategy
  • 2.3.6 Primary Interviews with Key Parkinson’s Disease Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players

• 3.1 Global Top Parkinson’s Disease Treatment Players by Market Size
  • 3.1.1 Global Top Parkinson’s Disease Treatment Players by Revenue (2015-2020)
  • 3.1.2 Global Parkinson’s Disease Treatment Revenue Market Share by Players (2015-2020)
  • 3.1.3 Global Parkinson’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Parkinson’s Disease Treatment Market Concentration Ratio
  • 3.2.1 Global Parkinson’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 10 and Top 5 Companies by Parkinson’s Disease Treatment Revenue in 2019
• 3.3 Parkinson’s Disease Treatment Key Players Head office and Area Served
• 3.4 Key Players Parkinson’s Disease Treatment Product Solution and Service
• 3.5 Date of Enter into Parkinson’s Disease Treatment Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

• 4.1 Global Parkinson’s Disease Treatment Historic Market Size by Type (2015-2020)
• 4.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Type (2021-2026)

5 Parkinson’s Disease Treatment Breakdown Data by Application (2015-2026)

• 5.1 Global Parkinson’s Disease Treatment Market Size by Application (2015-2020)
• 5.2 Global Parkinson’s Disease Treatment Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Parkinson’s Disease Treatment Market Size (2015-2020)
• 6.2 Parkinson’s Disease Treatment Key Players in North America (2019-2020)
• 6.3 North America Parkinson’s Disease Treatment Market Size by Type (2015-2020)
• 6.4 North America Parkinson’s Disease Treatment Market Size by Application (2015-2020)

7 Europe

• 7.1 Europe Parkinson’s Disease Treatment Market Size (2015-2020)
• 7.2 Parkinson’s Disease Treatment Key Players in Europe (2019-2020)
• 7.3 Europe Parkinson’s Disease Treatment Market Size by Type (2015-2020)
• 7.4 Europe Parkinson’s Disease Treatment Market Size by Application (2015-2020)

8 China

• 8.1 China Parkinson’s Disease Treatment Market Size (2015-2020)
• 8.2 Parkinson’s Disease Treatment Key Players in China (2019-2020)
• 8.3 China Parkinson’s Disease Treatment Market Size by Type (2015-2020)
• 8.4 China Parkinson’s Disease Treatment Market Size by Application (2015-2020)

9 Japan

• 9.1 Japan Parkinson’s Disease Treatment Market Size (2015-2020)
• 9.2 Parkinson’s Disease Treatment Key Players in Japan (2019-2020)
• 9.3 Japan Parkinson’s Disease Treatment Market Size by Type (2015-2020)
• 9.4 Japan Parkinson’s Disease Treatment Market Size by Application (2015-2020)

10 Southeast Asia

• 10.1 Southeast Asia Parkinson’s Disease Treatment Market Size (2015-2020)
• 10.2 Parkinson’s Disease Treatment Key Players in Southeast Asia (2019-2020)
• 10.3 Southeast Asia Parkinson’s Disease Treatment Market Size by Type (2015-2020)
• 10.4 Southeast Asia Parkinson’s Disease Treatment Market Size by Application (2015-2020)

11 India

• 11.1 India Parkinson’s Disease Treatment Market Size (2015-2020)
• 11.2 Parkinson’s Disease Treatment Key Players in India (2019-2020)
• 11.3 India Parkinson’s Disease Treatment Market Size by Type (2015-2020)
• 11.4 India Parkinson’s Disease Treatment Market Size by Application (2015-2020)

12 Central & South America

• 12.1 Central & South America Parkinson’s Disease Treatment Market Size (2015-2020)
• 12.2 Parkinson’s Disease Treatment Key Players in Central & South America (2019-2020)
• 12.3 Central & South America Parkinson’s Disease Treatment Market Size by Type (2015-2020)
• 12.4 Central & South America Parkinson’s Disease Treatment Market Size by Application (2015-2020)

13 Key Players Profiles

• 13.1 Teva
  • 13.1.1 Teva Company Details
  • 13.1.2 Teva Business Overview and Its Total Revenue
  • 13.1.3 Teva Parkinson’s Disease Treatment Introduction
  • 13.1.4 Teva Revenue in Parkinson’s Disease Treatment Business (2015-2020))
  • 13.1.5 Teva Recent Development
• 13.2 Roche
  • 13.2.1 Roche Company Details
  • 13.2.2 Roche Business Overview and Its Total Revenue
  • 13.2.3 Roche Parkinson’s Disease Treatment Introduction
  • 13.2.4 Roche Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.2.5 Roche Recent Development
• 13.3 Prothena
  • 13.3.1 Prothena Company Details
  • 13.3.2 Prothena Business Overview and Its Total Revenue
  • 13.3.3 Prothena Parkinson’s Disease Treatment Introduction
  • 13.3.4 Prothena Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.3.5 Prothena Recent Development
• 13.4 Acorda Therapeutics
  • 13.4.1 Acorda Therapeutics Company Details
  • 13.4.2 Acorda Therapeutics Business Overview and Its Total Revenue
  • 13.4.3 Acorda Therapeutics Parkinson’s Disease Treatment Introduction
  • 13.4.4 Acorda Therapeutics Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.4.5 Acorda Therapeutics Recent Development
• 13.5 Voyager Therapeutics
  • 13.5.1 Voyager Therapeutics Company Details
  • 13.5.2 Voyager Therapeutics Business Overview and Its Total Revenue
  • 13.5.3 Voyager Therapeutics Parkinson’s Disease Treatment Introduction
  • 13.5.4 Voyager Therapeutics Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.5.5 Voyager Therapeutics Recent Development
• 13.6 Impax Pharmaceuticals
  • 13.6.1 Impax Pharmaceuticals Company Details
  • 13.6.2 Impax Pharmaceuticals Business Overview and Its Total Revenue
  • 13.6.3 Impax Pharmaceuticals Parkinson’s Disease Treatment Introduction
  • 13.6.4 Impax Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.6.5 Impax Pharmaceuticals Recent Development
• 13.7 UCB
  • 13.7.1 UCB Company Details
  • 13.7.2 UCB Business Overview and Its Total Revenue
  • 13.7.3 UCB Parkinson’s Disease Treatment Introduction
  • 13.7.4 UCB Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.7.5 UCB Recent Development
• 13.8 AbbVie
  • 13.8.1 AbbVie Company Details
  • 13.8.2 AbbVie Business Overview and Its Total Revenue
  • 13.8.3 AbbVie Parkinson’s Disease Treatment Introduction
  • 13.8.4 AbbVie Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.8.5 AbbVie Recent Development
• 13.9 MSD
  • 13.9.1 MSD Company Details
  • 13.9.2 MSD Business Overview and Its Total Revenue
  • 13.9.3 MSD Parkinson’s Disease Treatment Introduction
  • 13.9.4 MSD Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.9.5 MSD Recent Development
• 13.10 Orion Pharmaceuticals
  • 13.10.1 Orion Pharmaceuticals Company Details
  • 13.10.2 Orion Pharmaceuticals Business Overview and Its Total Revenue
  • 13.10.3 Orion Pharmaceuticals Parkinson’s Disease Treatment Introduction
  • 13.10.4 Orion Pharmaceuticals Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 13.10.5 Orion Pharmaceuticals Recent Development
• 13.11 Intec Pharma
  • 10.11.1 Intec Pharma Company Details
  • 10.11.2 Intec Pharma Business Overview and Its Total Revenue
  • 10.11.3 Intec Pharma Parkinson’s Disease Treatment Introduction
  • 10.11.4 Intec Pharma Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 10.11.5 Intec Pharma Recent Development
• 13.12 NeuroDerm
  • 10.12.1 NeuroDerm Company Details
  • 10.12.2 NeuroDerm Business Overview and Its Total Revenue
  • 10.12.3 NeuroDerm Parkinson’s Disease Treatment Introduction
  • 10.12.4 NeuroDerm Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 10.12.5 NeuroDerm Recent Development
• 13.13 Adamas Therapeutics
  • 10.13.1 Adamas Therapeutics Company Details
  • 10.13.2 Adamas Therapeutics Business Overview and Its Total Revenue
  • 10.13.3 Adamas Therapeutics Parkinson’s Disease Treatment Introduction
  • 10.13.4 Adamas Therapeutics Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 10.13.5 Adamas Therapeutics Recent Development
• 13.14 Acadia
  • 10.14.1 Acadia Company Details
  • 10.14.2 Acadia Business Overview and Its Total Revenue
  • 10.14.3 Acadia Parkinson’s Disease Treatment Introduction
  • 10.14.4 Acadia Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 10.14.5 Acadia Recent Development
• 13.15 Sunovion
  • 10.15.1 Sunovion Company Details
  • 10.15.2 Sunovion Business Overview and Its Total Revenue
  • 10.15.3 Sunovion Parkinson’s Disease Treatment Introduction
  • 10.15.4 Sunovion Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 10.15.5 Sunovion Recent Development
• 13.16 GSK
  • 10.16.1 GSK Company Details
  • 10.16.2 GSK Business Overview and Its Total Revenue
  • 10.16.3 GSK Parkinson’s Disease Treatment Introduction
  • 10.16.4 GSK Revenue in Parkinson’s Disease Treatment Business (2015-2020)
  • 10.16.5 GSK Recent Development

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Disclaimer